Trials / Sponsors / BTG International Inc.

BTG International Inc.

Academic / Other · 12 registered clinical trials.

Status	Trial	Phase	Started
Completed	A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Breast Cancer	—	2023-06-06
Completed	Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation Snake Bites	Phase 4	2013-07-01
Completed	Copperhead Envenomation Observational Study Copperhead Snake Envenomation	—	2012-07-01
Completed	Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers Vaccine	Phase 1	2009-11-01
Terminated	High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma Osteosarcoma	Phase 2	2008-10-01
Terminated	Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma Hepatocellular Carcinoma	Phase 2	2008-09-01
Terminated	Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension Hypertension, Cardiovascular Disease	Phase 2	2008-06-01
Completed	Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Vorax Osteosarcoma, Leukemia, Lymphoma	Phase 1	2008-05-01
Completed	Retrospective Evaluation of CroFab - Efficacy in Severe Envenomation Snake Envenomation	—	2005-01-01
Completed	Efficacy Study of Digibind for Treatment of Severe Preeclampsia Pre-eclampsia	Phase 2	2004-02-01
Completed	Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance Neoplasms	Phase 2	2000-01-01
Approved For Marketing	Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity Neoplasms	—	—